Bulk Drug and API Plant Property Underwriting in India 2026: Solvent Fire Load, Reactor Hazard and Supply-Concentration BI

India is the third-largest producer of pharmaceuticals by volume and supplies a large share of the world's generic medicines, and a substantial part of that output depends on domestic manufacture of active pharmaceutical ingredients (APIs) and bulk drugs. The API base is concentrated in identifiable clusters: the Hyderabad and Telangana belt around Patancheru, Jeedimetla and Bollaram; the Gujarat belt around Ankleshwar, Vapi, Panoli and Vadodara; Visakhapatnam and the Andhra Pradesh coastal corridor; the Maharashtra Tarapur and Mahad belts; and the Himachal Pradesh, Sikkim and Baddi formulation clusters that draw on API supply. The government's bulk-drug park scheme and the Production-Linked Incentive scheme for APIs and key starting materials, intended to reduce import dependence on China, are adding fresh capacity through 2025 and 2026, which means more new-build and expansion property to underwrite.

API and bulk drug manufacture is chemically a fine-chemical and specialty-chemical process, not a packaging or formulation operation, and the property risk reflects that. The defining hazards are the large inventories of flammable organic solvents used as reaction media and for extraction, crystallisation and washing; the exothermic and sometimes hazardous reaction chemistry conducted in batch reactors; the high-temperature and high-pressure unit operations; and the storage and handling of flammable, toxic and reactive raw materials and intermediates. These hazards place API plants firmly in the high-hazard property class alongside specialty chemicals, distinct from the relatively benign formulation and packaging plants that the word pharmaceutical sometimes brings to mind.

The loss history confirms the hazard. Indian API clusters have a record of solvent fires, reactor explosions and runaway-reaction events, several with fatalities and with property losses running into tens or hundreds of crores. Fires originating in solvent storage and solvent-recovery sections, explosions in reactors processing energetic chemistry, and dust-and-vapour explosions in drying and milling operations recur across the cluster loss data. The market has experienced these losses directly, and property rates, survey requirements and risk-control conditions for API risks reflect a class that is loss-affected rather than benign.

For the underwriter and the broker, this means an API plant cannot be rated or placed as a generic pharmaceutical or as a light manufacturing risk. It requires the same process-safety scrutiny applied to a chemical plant: the solvent inventory and storage arrangement, the reactor chemistry and thermal hazards, the hazardous-area electrical classification, the fire protection appropriate to flammable liquids, the statutory PESO and Factories Act compliance, and a business interruption assessment that recognises both the long pharmaceutical re-validation timeline and the supply-concentration economics of the global API market. This post sets out each of those dimensions.

The single largest property exposure at an API plant is the flammable-solvent inventory. API synthesis is solvent-intensive: reactions are run in organic solvents, products are extracted and crystallised from solvents, equipment is washed with solvents, and large volumes of spent solvent are recovered by distillation for reuse. The common solvents (methanol, ethanol, isopropyl alcohol, acetone, methylene chloride, toluene, ethyl acetate, tetrahydrofuran, acetonitrile, n-hexane and others) span a wide flammability range, with many having low flash points and wide flammable ranges that make vapour ignition easy. A mid-size API plant can hold hundreds of kilolitres of solvent across the tank farm, the day tanks, the process vessels and the solvent-recovery section at any time.

The fire and explosion scenarios from this inventory define the maximum credible loss. The principal scenarios include a tank-farm fire involving one or more solvent storage tanks; a pool fire from a spill in a process or solvent-handling area that ignites; a flash fire or vapour-cloud explosion from a release of solvent vapour that finds an ignition source; a fire in the solvent-recovery and distillation section, which combines flammable inventory with high-temperature operation; and a warehouse fire involving drummed solvents or flammable raw materials. Each can escalate to involve adjacent process blocks if separation and protection are inadequate, and the combination of a solvent release with the energetic reactor chemistry described in the next section is where the most severe correlated losses occur.

The construction and layout factors the underwriter assesses

• Solvent storage design and separation: above-ground tank farm with adequate inter-tank spacing and bunding sized to contain the largest tank plus firewater, separation of the tank farm from process blocks and from the boundary, and segregation of incompatible materials. Underground or mounded storage and nitrogen blanketing of tanks are positive features.
• Bunding and containment: dyke capacity, drainage routed to a safe interceptor rather than to open drains, and prevention of solvent migration across the site during a spill or firefighting.
• Process-block layout and inter-unit spacing: separation of solvent-handling and reaction blocks from utilities, warehouses, quality control and administration, and adequate spacing to limit fire spread between blocks.
• Solvent-recovery section: the distillation columns, condensers and recovered-solvent tanks combine flammable inventory with thermal energy and are a recurring ignition point; their protection and isolation are specifically assessed.
• Warehouse classification: dedicated flammable-storage warehouses with appropriate construction, ventilation, detection and suppression, separated from non-hazardous storage.

The fire-protection expectation for the solvent exposure is that of a flammable-liquid facility, not a general warehouse. That means foam-based suppression for tank farms and solvent areas (fixed foam systems or foam-water sprinklers), adequate firewater storage and pump redundancy, hydrant coverage consistent with the fire-protection norms the market references, gas and flame detection in solvent-handling and recovery areas, and emergency isolation and shutdown. The presence, design and tested condition of these systems is a primary rating and acceptance input, and a plant that relies on a general hydrant system without foam capability for its solvent exposure presents materially worse than one with proper flammable-liquid protection.

Beyond the solvent inventory, the reaction chemistry itself is a property hazard. API synthesis frequently involves exothermic reactions, reactive and unstable intermediates, energetic functional groups (nitro, azide, diazo and peroxide chemistry in some routes), and hydrogenation and other reactions under pressure. The batch reactor, the workhorse of API manufacture, is where this chemistry is conducted, and reactor incidents (runaway reactions, overpressure, loss of cooling, charging errors) are a documented source of major loss at Indian API plants.

A runaway reaction occurs when the heat generated by an exothermic reaction exceeds the rate at which the reactor cooling can remove it. The temperature rises, the reaction rate accelerates, the temperature rises faster, and the reactor can reach a point of thermal runaway leading to overpressure, vessel rupture, release of flammable and toxic contents, and fire or explosion. The triggers include cooling-system failure, agitation failure (loss of mixing that allows reactant accumulation followed by a sudden uncontrolled reaction), charging errors (wrong material or wrong quantity), and inadequate understanding of the thermal hazards of the chemistry. Hydrogenation reactions add the hazard of hydrogen, a wide-flammable-range gas. The consequence of a reactor event can range from a contained relief discharge to a vessel failure that destroys the reaction block and ignites surrounding solvent inventory.

Process-safety inputs the underwriter expects

The quality of process-safety management is the dominant variable separating a well-run API plant from a dangerous one, and underwriters and process-safety surveyors examine it closely. The expected elements include:

• Reaction-hazard understanding: thermal-stability and reaction-calorimetry data for the chemistry (characterising the heat of reaction, the onset temperature of decomposition and the consequences of cooling loss), and process design based on that data.
• Reactor safeguards: adequate cooling capacity with backup, agitation monitoring and interlocks, temperature and pressure monitoring with alarms and trips, emergency cooling or quench provision, and properly sized pressure relief discharging to a safe location (a catch tank, scrubber or flare rather than the building).
• Process safety management system: hazard and operability studies, layer-of-protection analysis, management of change for process and chemistry changes, safe operating procedures, and operator competence and training.
• Basic process control and safety instrumented systems: the distinction between the control system that runs the process and the independent safety system that brings it to a safe state, with the safety system designed to an appropriate integrity level for the hazard.

The other thermal and process exposures at an API plant include the drying operations (vacuum tray dryers, fluid-bed dryers and others, where solvent-wet product and combustible powders create both vapour and dust explosion hazards), the milling and micronisation operations (dust explosion hazard with fine organic powders), the hydrogenation and high-pressure operations (pressure-vessel and gas hazards under PESO), and the thermal utilities (boilers and thermic-fluid heaters that supply process heat, themselves a fire and explosion exposure). Each is a property exposure with specific safeguards the underwriter reviews. The dust-explosion exposure in drying and milling is often under-appreciated, and a basis-of-safety for combustible powder handling (inerting, explosion venting, suppression or containment) is part of a credible risk presentation.

The interaction between the reactor chemistry and the solvent inventory is what produces the worst losses. A reactor event that releases solvent into a process block already holding flammable inventory, or a solvent fire that escalates to involve reactors, combines two hazards into a single severe event. The underwriter's maximum-credible-loss assessment has to consider these correlated scenarios, not just the standalone tank fire or the standalone reactor failure.

The flammable-vapour environment of an API plant requires a defined approach to electrical equipment and ignition control, and that approach sits inside a statutory framework. Compliance with the framework is both a legal obligation for the insured and an underwriting precondition; surveyors examine the documentation, and gaps attract conditions or declinature.

Hazardous-area classification is the discipline of identifying the areas where flammable vapour or gas may be present and specifying that only electrical equipment certified for those areas is used there. Areas are classified into zones by the likelihood and duration of a flammable atmosphere (the continuous, occasional and unlikely categories), and equipment in each zone must carry the appropriate protection certification (flameproof, intrinsically safe, increased safety and other recognised types). The hazardous-area classification drawing, the equipment certification, and the discipline that no uncertified electrical source is introduced into a classified area are core ignition-control measures. The Bureau of Indian Standards codes and the Central Electricity Authority and Petroleum and Explosives Safety Organisation requirements govern this, and the underwriter expects to see a current area-classification drawing, an equipment register confirming certified equipment in classified zones, and evidence that the classification is maintained as the plant changes.

PESO regulates several aspects of an API plant. Flammable-liquid storage above the threshold quantities requires PESO licensing under the Petroleum Rules, with prescribed tank-farm design, separation distances and safety provisions. Compressed and liquefied gases (hydrogen, nitrogen and others) under pressure engage the gas-cylinder and pressure-vessel rules. Unfired pressure vessels engage the Static and Mobile Pressure Vessels (Unfired) Rules where the thresholds are met, requiring approved design, periodic statutory inspection and certification. The PESO licences, the approved layouts and the current inspection certificates are documents the surveyor will request and the underwriter will rely on.

The Factories Act 1948 and the state factory rules govern occupational safety, and an API plant handling hazardous processes attracts the additional provisions for hazardous processes, including the safety committee, the disclosure of information, the medical surveillance and the on-site emergency planning. Where the plant handles hazardous chemicals above the MSIHC Rules thresholds, the Manufacture, Storage and Import of Hazardous Chemicals Rules apply, requiring safety reports, on-site and off-site emergency plans and notification, and a plant classified as a Major Accident Hazard installation carries the fullest set of obligations. The Boilers Act covers the steam boilers, the state pollution control board consents under the Water and Air Acts cover effluent and emissions, and the environmental clearance under the EIA framework covers the original and expanded capacity.

The compliance pack the underwriter relies on

1. The PESO petroleum-storage and pressure-vessel licences and current inspection certificates.
2. The hazardous-area classification drawing and the certified-equipment register.
3. The Factories Act licence, the hazardous-process compliance and the on-site emergency plan, with MSIHC documentation where in scope.
4. The pollution control board consents and the environmental clearance for the installed and expanded capacity.
5. The process-safety documentation: the hazard studies, the reaction-hazard data and the management-of-change records.

The value of this pack to the underwriter is that it discriminates between a plant operated to fine-chemical process-safety standards and one operated as if it were a benign formulation unit. The same nominal hazard, well-managed, is an acceptable risk; poorly managed, it is the kind of risk that produces the cluster loss history. The broker who curates this pack before approaching the market positions the risk for the better terms that a demonstrably well-run plant deserves.

The Indian API clusters have a loss record that directly shapes how the market underwrites the class, and understanding the recurring patterns helps the broker present a risk credibly and helps the underwriter focus the survey and the conditions on what actually drives losses.

The recurring loss patterns are consistent across the Telangana, Gujarat, Andhra Pradesh and Maharashtra clusters. Solvent-section fires, originating in storage, handling or recovery and spreading to adjacent process areas, are the most frequent major property loss. Reactor explosions and runaway reactions, often involving energetic chemistry or a loss of cooling or agitation, produce some of the most severe events with fatalities. Dust and vapour explosions in drying and milling operations recur, sometimes initiating a larger solvent fire. Effluent and waste-handling incidents, including reactions in mixed-waste streams and solvent-laden effluent, feature in the record. Hydrogenation and high-pressure gas incidents, while less frequent, are high-consequence when they occur.

The lessons the market has drawn from this record are practical. First, the solvent inventory and its protection are the first thing to assess, because solvent fires are the most frequent severe loss and the protection quality varies widely across the cluster. Second, the process-safety management maturity is the best predictor of reactor and process losses; plants with genuine hazard studies, reaction-hazard data and disciplined management of change have a materially better record than plants that run chemistry without that understanding. Third, the housekeeping and the operational discipline visible at survey (solvent handling practice, spill management, hot-work control, electrical-equipment condition in classified areas) correlate with the loss experience and are legitimate underwriting signals. Fourth, the concentration of plants within a cluster creates a fire-spread and a market-accumulation dimension that matters for both the individual risk and the insurer's portfolio.

Implications for survey, conditions and pricing

The loss history justifies a process-safety-led survey for any material API risk, conducted by a surveyor competent in chemical process hazards rather than a generalist, examining the solvent storage and protection, the reactor safeguards and process-safety system, the hazardous-area classification, the drying and milling basis of safety, and the statutory compliance. It justifies risk-control conditions tied to the specific exposures: foam protection for the solvent areas, defined hot-work and electrical-integrity controls, and closure of identified survey recommendations within agreed timeframes. And it justifies pricing that places API plants in the specialty-chemical band, differentiated sharply by the demonstrated process-safety maturity and protection quality of the individual plant.

For the broker, the loss history is the context that makes a strong risk presentation valuable. A plant that can demonstrate, through documentation and a clean survey, that it manages the solvent fire exposure with proper protection, that it understands and controls its reaction hazards, and that it complies with the PESO, Factories Act and hazardous-process framework, separates itself from the cluster average and earns the better terms. The broker's role is to assemble and present that evidence, and to ensure that the property and machinery programme, the liability and statutory PLI Act cover, the employer's liability and any environmental cover are constructed together to respond to the correlated property, worker-safety and pollution scenarios that the loss history shows are real.

Business interruption is often the larger part of the loss at an API plant, and it has two features that distinguish it from a generic manufacturing BI: the pharmaceutical re-validation and regulatory timeline that extends the recovery, and the supply-concentration economics that can make a single plant's output critical to customers far beyond its own revenue.

The re-validation timeline is the first feature. An API plant cannot simply repair the physical damage and resume; the affected facilities, equipment and processes must be re-qualified and re-validated to good-manufacturing-practice standards before the product can be sold, and where the plant supplies regulated markets, the relevant regulators may need to re-inspect and re-approve the site. Reconstructing a damaged block, re-installing and re-qualifying equipment, re-validating the process, and securing the necessary regulatory approvals (the Indian drug regulator and, for export, the US FDA, the European authorities and others depending on the markets served) can extend the recovery well beyond the physical repair. An indemnity period set to the physical repair time will fall short; the indemnity period has to cover the re-qualification, re-validation and re-approval sequence, which can run many months to well over a year for a serious loss to a multi-product block.

Sizing the indemnity period and the BI basis

The indemnity period should be set to the realistic worst-case sequence: physical reconstruction, equipment procurement (some specialised equipment has long lead times), re-qualification and re-validation, regulatory re-inspection and re-approval where applicable, and ramp-up to full output. For a plant serving regulated export markets, the regulatory re-approval step can be the long pole. Twenty-four months is a more realistic starting point than twelve for a material block loss, and complex multi-product or export-critical sites may need longer. The BI basis (gross profit, with the standard treatment of continuing fixed costs and the saved variable costs) should be defined clearly, and the sum insured should reflect the actual margin and the extended indemnity period rather than a nominal figure.

The supply-concentration feature is the second and more strategic one. Indian API plants frequently supply a large share of the global production of specific molecules; for some APIs and key starting materials, a single plant or a small number of plants account for the bulk of world supply, a concentration that the COVID-19 supply shocks and the China-dependence concerns made visible and that the PLI scheme is intended to address. This concentration cuts two ways for the insurance assessment. For the API plant's own BI, the concentration can support a strong recovery because customers have nowhere else to go and will wait, but it also exposes the plant to contractual penalties and customer-relationship loss if it cannot supply. For the wider market, it creates a contingent business interruption exposure for the formulators and pharmaceutical companies downstream who depend on that API; a loss at a critical API plant can interrupt formulation operations far away, which is a CBI exposure those downstream insureds should map.

Contingent exposures and accumulation

The contingent dimension runs in both directions. The API plant depends on its own upstream suppliers of key starting materials and intermediates, many themselves concentrated, so a loss at an upstream supplier can interrupt the API plant (a contingent business interruption for the API plant). The formulators downstream depend on the API plant, so a loss at the API plant can interrupt them (a contingent business interruption for the formulators). Mapping these dependencies at placement, and deciding which contingent exposures to insure and at what limits, is part of a properly constructed pharmaceutical programme. For the insurer, the cluster concentration also creates a portfolio accumulation: a single cluster event affecting multiple plants, or the correlated dependence of many downstream insureds on a few API plants, is an accumulation to monitor.

Constructing an API plant programme well means holding the material damage, machinery breakdown, business interruption (including the extended re-validation indemnity period), contingent business interruption, public liability and statutory PLI Act, employer's liability and environmental wordings in view together, and aligning their triggers, sub-limits, indemnity periods and exclusions so that the correlated property, supply-chain, worker-safety and pollution scenarios that the cluster loss history shows are real do not fall into a gap between policies. Sarvada gives commercial insurance brokers structured, searchable access to insurer policy wordings so they can compare triggers, grants, sub-limits and exclusions across the property, machinery, BI and liability sections side by side and build a pharmaceutical and API programme without coverage gaps. Request Access to evaluate the platform for API and bulk drug risks.